Clinical Trial Update: The Outcome of Preoperative Administration of Single-dose Ketorolac, Non-steroidal Anti-inflammatory Drug and Placebo [NA]

View source ↗

Summary

This trial evaluated preoperative single-dose ketorolac versus placebo for irreversible pulpitis and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irreversible Pulpitis

Drugs mentioned

• Ketorolac (Ketorolac tromethamine)

Snippet

Sponsor: Universidad Autonoma de Baja California | Conditions: Pulpitis - Irreversible | NA | Status: COMPLETED